Avanos Recalls Ballard Closed Suction Systems

Due to sterilization failure

May result in non-sterile devices

Avanos Medical, Inc. is recalling its Ballard Closed Suction Systems after identifying a failure in the sterilization process, which may result in non-sterile devices. Use of these products could lead to serious health risks, including infection, airway injury, inflammation, sepsis, or death.

No injuries or deaths have been reported to date.

About the Device

The Ballard Closed Suction System is used for removing airway secretions in ventilated patients, helping to maintain ventilation without disconnecting the circuit — a critical function in respiratory care.

Recommended Actions (as of March 19, 2025)

  • Immediately stop using any affected products and quarantine them.
  • Check your inventory for affected items listed in the recall notice.
  • Notify any customers or departments you may have shared the product with.
  • Complete and return the Response Form to: productquality@myairlife.com.
  • Arrange for return or confirm destruction of affected units to receive replacements.
  • Communicate the recall to all relevant staff within your organization.
  • For urgent replacement needs, contact AirLife at 1-800-433-2797.

Need Help?

For questions or support related to the recall, contact Avanos Medical, Inc. at 1-800-433-2797.

Healthcare providers are urged to act promptly to prevent potential harm to patients relying on these critical airway management systems.

Affected Products

Affected Product

Product Names:

  • Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Y-Adapter
  • Ballard Closed Suction System for Neonates/Pediatrics, 10 F, Elbow 
  • Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Elbow
  • Ballard Closed Suction System for Adults, 14 F, T-Piece 
  • Ballard Closed Suction System for Adults, 14 F, DSE
  • Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE, MDI 
  • Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE

Click here to see a full list of affected devices.

Postmarket Surveillance – from QSR to QMSR

How QSR Postmarket Surveillance Will Evolve Under the QMSR  As medical device manufacturers transition from the FDA’s Quality System Regulation (QSR) to the new Quality Management System Regulation (QMSR), one area undergoing significant change is postmarket...

Medical Device Labeling

In the world of medical devices, proper labeling isn't just a regulatory requirement, it is a vital component of patient safety, product usability, and market access. Whether you're a manufacturer navigating FDA regulations, a distributor handling multilingual...

QMSR Clause 8 – Measurement Analysis and Improvement

ISO 13485 Clause 8 Transition Notes  The QMSR eliminates FDA-specific structure in favor of ISO 13485:2016 clauses. All above ISO 13485 clauses are now explicit requirements under QMSR.  New documentation and risk-based decision-making are emphasized throughout the...